Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet

被引:30
作者
Mitchell, BL
Yasui, Y
Lampe, JW
Gafken, PR
Lampe, PD
机构
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[2] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA
[3] Univ Washington, Dept Biostat, Seattle, WA 98109 USA
[4] Univ Washington, Dept Epidemiol, Seattle, WA 98109 USA
[5] Univ Washington, Dept Pathobiol, Seattle, WA 98109 USA
关键词
alpha2-HS; biomarkers; diet; glycoprotein; mass spectrometry; serum;
D O I
10.1002/pmic.200401099
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Biomarkers have the potential to impact a wide range of public health concerns, including early detection of diseases, drug discovery, and improved accuracy of monitoring effects of interventions. Given new technological developments, broad-based screening approaches will likely advance biomarker discovery at an accelerated pace. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) allows for the elucidation of individual protein masses from a complex mixture with high throughput. We have developed a method for identifying serum biomarkers using MALDI-TOF and statistical analysis. However, before applying this approach to screening of complex diseases, we evaluated the approach in a controlled dietary intervention study. In this study, MALDI-TOF spectra were generated using samples from a randomized controlled trial. During separate feeding periods, 38 participants ate a basal diet devoid of fruits and vegetables and a basal diet supplemented with cruciferous (broccoli) family vegetables. Serum samples were obtained at the end of each 7-day feeding period and treated to remove large, abundant proteins. MALDI-TOF spectra were analyzed using peak picking algorithms and logistic regression models. Our bioinformatics methods identified two significant peaks at m/z values of 2740 and 1847 that could classify participants based on diet (basal vs. cruciferous) with 76 % accuracy. The 2740 m/z peak was identified as the B-chain of alpha 2-H S glycoprotein, a serum protein previously found to vary with diet and be involved in insulin resistance and immune function.
引用
收藏
页码:2238 / 2246
页数:9
相关论文
共 36 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]   Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry [J].
Adkins, JN ;
Varnum, SM ;
Auberry, KJ ;
Moore, RJ ;
Angell, NH ;
Smith, RD ;
Springer, DL ;
Pounds, JG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (12) :947-955
[3]   Ovarian cancer detection by logical analysis of proteomic data [J].
Alexe, G ;
Alexe, S ;
Liotta, LA ;
Petricoin, E ;
Reiss, M ;
Hammer, PL .
PROTEOMICS, 2004, 4 (03) :766-783
[4]   Alpha2-HS glycoprotein: a protein in search of a function [J].
Arnaud, P ;
Kalabay, L .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (04) :311-314
[5]   Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments [J].
Baggerly, KA ;
Morris, JS ;
Coombes, KR .
BIOINFORMATICS, 2004, 20 (05) :777-U710
[6]   Diagnostic potential of serum proteomic patterns in prostate cancer [J].
Bañez, LL ;
Prasanna, P ;
Sun, L ;
Ali, A ;
Zou, ZQ ;
Adam, BL ;
McLeod, DG ;
Moul, JW ;
Srivastava, S .
JOURNAL OF UROLOGY, 2003, 170 (02) :442-446
[7]   Cleavage N-terminal to proline: Analysis of a database of peptide tandem mass spectra [J].
Breci, LA ;
Tabb, DL ;
Yates, JR ;
Wysocki, VH .
ANALYTICAL CHEMISTRY, 2003, 75 (09) :1963-1971
[8]   Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems [J].
Diamandis, EP .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05) :353-356
[9]   Point - Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics? [J].
Diamandis, EP .
CLINICAL CHEMISTRY, 2003, 49 (08) :1272-1275
[10]   Proteomic patterns in serum and identification of ovarian cancer [J].
Diamandis, EP .
LANCET, 2002, 360 (9327) :170-170